CHO Pharma Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Jun '25 Jun 26, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	8,582	11,022	14,830	25,204	15,354	4,575	Upgrade
Market Cap Growth	-25.68%	-25.68%	-41.16%	64.15%	235.65%	3.48%	Upgrade
Enterprise Value	6,245	8,568	13,944	24,033	13,969	2,948	Upgrade
Last Close Price	40.10	51.50	69.30	137.00	83.50	24.90	Upgrade
PS Ratio	2397.16	3078.64	-	420067.12	4300.98	33148.76	Upgrade
PB Ratio	3.12	4.01	4.99	17.64	8.80	2.33	Upgrade
P/TBV Ratio	3.69	4.74	5.83	27.06	12.44	3.19	Upgrade
EV/Sales Ratio	-	2393.25	-	400545.33	3912.99	21363.14	Upgrade
Debt / Equity Ratio	0.01	0.01	-	0.01	0.02	0.02	Upgrade
Asset Turnover	0.00	0.00	-	0	0.00	0	Upgrade
Quick Ratio	20.41	20.41	24.57	6.19	9.89	10.22	Upgrade
Current Ratio	20.81	20.81	24.93	6.39	10.06	10.37	Upgrade
Return on Equity (ROE)	-7.41%	-7.41%	-13.90%	-21.33%	-11.11%	-14.05%	Upgrade
Return on Assets (ROA)	-5.22%	-5.22%	-7.17%	-12.55%	-6.52%	-8.47%	Upgrade
Return on Capital (ROIC)	-5.42%	-5.42%	-7.61%	-13.66%	-6.98%	-8.99%	Upgrade
Earnings Yield	-2.47%	-1.93%	-2.06%	-1.34%	-1.34%	-6.49%	Upgrade
FCF Yield	-2.60%	-2.02%	-1.98%	-1.03%	-1.28%	-5.86%	Upgrade
Buyback Yield / Dilution	-11.86%	-11.86%	-4.00%	-0.04%	-0.12%	-0.36%	Upgrade

Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.